In September 2024, we proudly participated in BIOHK 2024 as a startup exhibitor. This prestigious event brought together the brightest minds and leading companies in biotechnology and life sciences, offering an exceptional platform to showcase innovative technologies and explore the future of the industry.
About BIOHK 2024
BIOHK 2024 is a global gathering dedicated to presenting cutting-edge technologies, integrating stakeholders, and accelerating the commercialization, translation, and industrialization of groundbreaking research. The event attracted top-tier companies, research institutions, and investors from around the world, fostering collaborations and advancing industry growth.
Our Featured Innovation
At BIOHK 2024, we showcased our AI-powered deep learning service for personalized liver cancer treatment planning, highlighting its transformative potential in clinical practice:
- Comprehensive Data Integration: Our system combines imaging, pathology, and genomic data to deliver precise disease assessments and tailored treatment recommendations.
- Smart Diagnostic Assistance: Utilizing advanced deep learning models, it automates liver image analysis and integrates genomic insights to provide personalized recommendations for targeted therapies, efficacy predictions, and prognosis assessments.
- Similar Patient Search: The system offers a tool for physicians to explore similar cases, aiding in the development of optimized treatment strategies.
- Validated through Clinical Trials: The solution is currently undergoing multicenter clinical trials to ensure its safety and feasibility in real-world clinical applications.
Our technology not only enhances the accuracy of early liver cancer detection but also enables real-time monitoring of treatment responses, empowering physicians to provide the most suitable treatment plans for their patients. This represents a significant step forward in personalized and precision medicine.
Engagement with Industry Leaders
We were honored to take part in a photo opportunity with Professor Yu Changhai, Chairman of the Hong Kong Biotechnology Organization, during the event. As a prominent leader in the biotechnology field, Professor Yu’s presence underscored the event’s significance and further highlighted the importance of fostering innovation in the industry.
Participation in BIOHK 2024 was a milestone for our company, offering us a platform to demonstrate our cutting-edge technology and gain recognition on the global stage. This experience inspires us to continue innovating and advancing personalized and precision medicine.
Looking ahead, we remain committed to collaboration and innovation, working with industry peers to drive the clinical application and industrialization of breakthrough technologies in biotechnology and life sciences.